Ocular Therapeutix is a biopharmaceutical company that develops therapies for the eye using its hydrogel-based formulation technology. Its products include ReSure Sealant and DEXTENZA, and the company is working on several other treatments in clinical trials for various eye conditions. Ocular Therapeutix has collaborations with Regeneron Pharmaceuticals and AffaMed Therapeutics, as well as a discovery partnership with Mosaic Biosciences.